InkMune clinical trial goes on: second cohort is being treated

[Maxone73]

In phase 1/2 CaRe PC trial (NCT06056791) evaluating INKmune, a biologic therapy

In its announcement on Monday, INmune said it successfully completed nine INKmune administrations in the outpatient setting within the first cohort in the trial. None of the patients who have received INKmune so far have experienced significant adverse events or required conditioning therapy, premedication, or cytokine support, according to the firm....ad it might even work!

"INKmune converts the patient's own NK cells in their circulation and probably actually within their tumor from resting non-cancer killing state to what we now know are memory like NK cells that are able to destroy NK resistant cancer cells."

I am waiting for some initial findings on other data apart from toxicity, let's hope!

investing.com/news/stock-ma...

[God_Loves_Me]

Farmhand FYI

[Derf4223]

Thanks maxone73

[Maxone73 in reply to Derf4223]

No prob!

[inthefight]

Thank you Maxone. We are saving lots of your posts for future reference. Hopefully we will not need them for a long time.

[Maxone73 in reply to inthefight]

no prob!! I am hoping for the same!

[j-o-h-n]

If it works, you receive a personalized engraved 14k gold filled writing pen....All you have to do is change your name to Cross.

Good Luck, Good Health and Good Humor.

j-o-h-n